Proposed Swedish Pharma Pricing Model Suggests VBP Is Not Enough To Control Costs
This article was originally published in The Pink Sheet Daily
Executive Summary
The new government directive on pricing and reimbursement leaves industry fearing that reference prices will be added to Sweden's value-based pricing system to cut costs.